Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Workman

Showing results (81-90 of 315) with videos related to

Pageof 32
Sort By:
Oncotarget|November 24, 2012
Inhibiting the molecular evolution of cancer through HSP90Ana Sofia Martins, Faith E Davies, Paul Workman
Cancer Cell|April 21, 2012
Personalized medicine: patient-predictive panel powerPaul Workman, Paul A Clarke, Bissan Al-Lazikani
European Journal of Cancer (Oxford, England : 1990)|November 16, 2004
Gene expression microarray technologies in the development of new therapeutic agentsPaul A Clarke, Robert te Poele, Paul Workman
Current Opinion in Pharmacology|July 2, 2013
Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncologyPaul Workman, Bissan Al-Lazikani, Paul A Clarke
Cell Cycle (Georgetown, Tex.)|March 17, 2012
The expanding proteome of the molecular chaperone HSP90Rahul S Samant, Paul A Clarke, Paul Workman
Cell Cycle (Georgetown, Tex.)|August 23, 2011
Exploiting tumor metabolism for non-invasive imaging of the therapeutic activity of molecularly targeted anticancer agentsMounia Beloueche-Babari, Paul Workman, Martin O Leach
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2014
E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cellsRahul S Samant, Paul A Clarke, Paul Workman
Drug Discovery Today|February 2, 2020
From patent to patient: analysing access to innovative cancer drugsEva Sharpe, Richard Hoey, Christina Yap, et al.
Plos One|May 26, 2017
SiGNet: A signaling network data simulator to enable signaling network inferenceElizabeth A Coker, Costas Mitsopoulos, Paul Workman, et al.
Methods (San Diego, Calif.)|June 11, 2002
Assays for the identification and evaluation of histone acetyltransferase inhibitorsG Wynne Aherne, Martin G Rowlands, Lindsay Stimson, et al.
Pageof 32

Showing results (81-90 of 315) with videos related to

Sort By:
Pageof 32
Oncotarget|November 24, 2012
Inhibiting the molecular evolution of cancer through HSP90Ana Sofia Martins, Faith E Davies, Paul Workman
Cancer Cell|April 21, 2012
Personalized medicine: patient-predictive panel powerPaul Workman, Paul A Clarke, Bissan Al-Lazikani
European Journal of Cancer (Oxford, England : 1990)|November 16, 2004
Gene expression microarray technologies in the development of new therapeutic agentsPaul A Clarke, Robert te Poele, Paul Workman
Current Opinion in Pharmacology|July 2, 2013
Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncologyPaul Workman, Bissan Al-Lazikani, Paul A Clarke
Cell Cycle (Georgetown, Tex.)|March 17, 2012
The expanding proteome of the molecular chaperone HSP90Rahul S Samant, Paul A Clarke, Paul Workman
Cell Cycle (Georgetown, Tex.)|August 23, 2011
Exploiting tumor metabolism for non-invasive imaging of the therapeutic activity of molecularly targeted anticancer agentsMounia Beloueche-Babari, Paul Workman, Martin O Leach
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2014
E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cellsRahul S Samant, Paul A Clarke, Paul Workman
Drug Discovery Today|February 2, 2020
From patent to patient: analysing access to innovative cancer drugsEva Sharpe, Richard Hoey, Christina Yap, et al.
Plos One|May 26, 2017
SiGNet: A signaling network data simulator to enable signaling network inferenceElizabeth A Coker, Costas Mitsopoulos, Paul Workman, et al.
Methods (San Diego, Calif.)|June 11, 2002
Assays for the identification and evaluation of histone acetyltransferase inhibitorsG Wynne Aherne, Martin G Rowlands, Lindsay Stimson, et al.
Pageof 32